We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

96 hedge funds and large institutions have $201M invested in Adverum Biotechnologies in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

436% more call options, than puts

Call options by funds: $3.96M | Put options by funds: $739K

229% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 14

198% more capital invested

Capital invested by funds: $67.3M → $201M (+$133M)

85% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 13

48% more funds holding

Funds holding: 65 → 96 (+31)

1.3% more ownership

Funds ownership: 4.27% → 5.57% (+1.3%)

Holders
96
Holders Change
+31
Holders Change %
+47.69%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
46
Increased
24
Reduced
13
Closed
14
Calls
$3.96M
Puts
$739K
Net Calls
+$3.23M
Net Calls Change
+$1.88M

Top Buyers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
+$11.6M
2
JP Morgan Chase
JP Morgan Chase
New York
+$11.6M
3
Alkeon Capital Management
Alkeon Capital Management
New York
+$9.31M
4
Millennium Management
Millennium Management
New York
+$8.88M
5
Citadel Advisors
Citadel Advisors
Florida
+$8.27M

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$2.8M
2
TCM
Tekla Capital Management
Massachusetts
-$2.6M
3
SC
Sessa Capital
New York
-$2.23M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2M
5
6CM
683 Capital Management
New York
-$1.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Casdin Capital
New York
$1.74M +$1.87M +30,000 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.63M +$1.16M +18,610 +195%
OAM
28
Oxford Asset Management
United Kingdom
$1.57M +$1.44M +23,182 +595%
Deutsche Bank
29
Deutsche Bank
Germany
$1.5M -$781K -12,539 -33%
IHM
30
Iguana Healthcare Management
New York
$1.16M – – –
SM
31
Sabby Management
Florida
$1.15M -$629K -10,104 -34%
ACM
32
Atika Capital Management
New York
$1.13M +$1.21M +19,500 New
BCM
33
Bridgeway Capital Management
Texas
$1.1M +$33K +530 +3%
RI
34
RTW Investments
New York
$1.02M +$1.09M +17,521 New
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$996K -$148K -2,380 -12%
Victory Capital Management
36
Victory Capital Management
Texas
$949K +$1.02M +16,358 New
BCM
37
BlueCrest Capital Management
Jersey
$923K +$794K +12,747 +402%
BFM
38
Boothbay Fund Management
New York
$772K +$526K +8,442 +174%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$741K +$375K +6,020 +89%
RPAM
40
Rhenman & Partners Asset Management
Sweden
$737K – – –
TEE
41
Tibra Equities Europe
United Kingdom
$627K +$673K +10,806 New
ECM
42
Element Capital Management
New York
$603K +$647K +10,390 New
AAP
43
Ardsley Advisory Partners
Connecticut
$580K – – –
Northern Trust
44
Northern Trust
Illinois
$579K +$121K +1,949 +24%
Barclays
45
Barclays
United Kingdom
$556K +$382K +6,143 +178%
Alyeska Investment Group
46
Alyeska Investment Group
Illinois
$528K +$567K +9,100 New
PA
47
Perceptive Advisors
New York
$469K +$503K +8,085 New
Invesco
48
Invesco
Georgia
$424K +$455K +7,305 New
AG
49
Algert Global
California
$423K +$454K +7,298 New
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$405K -$116K -1,870 -21%
1
2
3 4 5

ADVM Hedge Fund Activity: Q1 2018 in Review

96 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q1 2018, worth a combined $201M — up 198% from $67.3M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new ADVM positions and 14 closed out — a net gain of 32 holders — while 24 added to existing stakes and 13 trimmed.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $11.6M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $2.8M sold.

  • 96 institutional investors held Adverum Biotechnologies (ADVM) as of Q1 2018, up from 65 in Q4 2017.
  • Funds reported $201M of Adverum Biotechnologies stock for Q1 2018, up 198% quarter-over-quarter.
  • 46 funds opened new Adverum Biotechnologies positions in Q1 2018 and 14 closed out, a net change of +32 holders.
  • The largest Adverum Biotechnologies buyer in Q1 2018 was Driehaus Capital Management, an estimated $11.6M added.
  • The largest Adverum Biotechnologies seller in Q1 2018 was Rubric Capital Management (New York), an estimated $2.8M sold.

Based on aggregated 13F filings for Q1 2018.